View Older Stories View More Recent Stories

Mar 30, 2021 08:00AM Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

Mar 30, 2021 07:00AM AavantiBio Appoints Dr. Christopher Wright as Chief Medical Officer

Mar 29, 2021 04:30PM Form SC 13D Connect Biopharma Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 25, 2021 05:00PM Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

Mar 25, 2021 05:00AM Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders

Mar 24, 2021 04:31PM Form SC 13G PhaseBio Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 23, 2021 04:32PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 23, 2021 08:30AM PepGen to Present at Stifel's 3rd Annual CNS Day

Mar 22, 2021 02:30PM Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Closing of $149.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option to Purchase

Mar 18, 2021 11:40AM IPO for SPAC Research Alliance Corp. II (RACB) Opened at $10.22

Mar 17, 2021 11:40PM Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Pricing of $130 Million Initial Public Offering

Mar 15, 2021 04:38PM Form SC 13G/A Viridian Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 15, 2021 07:30AM Graphite Bio Secures $150 Million Series B Financing to Advance Pipeline of Next-Generation Gene Editing Therapies

Mar 15, 2021 06:35AM POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I (RACA)

Mar 15, 2021 06:00AM Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Mar 15, 2021 06:00AM Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Mar 15, 2021 06:00AM PepGen to Present Late-Breaking Data from Novel Enhanced Delivery Oligonucleotide (EDO) Pipeline at 2021 Muscular Dystrophy Association Virtual Clinical and Scientific Conference

Mar 11, 2021 04:10PM Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Mar 11, 2021 08:00AM Covid Apollo Project Makes Investment in Rhinostics to Accelerate Covid-19 Testing Volumes Through High Throughput Sample Accessioning

Mar 11, 2021 07:00AM AavantiBio Bolsters Leadership Team with Appointment of Ty Howton as Chief Operating Officer and General Counsel

Mar 9, 2021 04:31PM Form SC 13G ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 4, 2021 09:00AM Hydrus Microstent Now First MIGS Device Proven With 5-Year Pivotal Trial Data; Results Show Over 60% Reduction in Secondary Glaucoma Surgeries, Sustained Reduction in Medication Use

Mar 3, 2021 08:00AM Janux Therapeutics Announces $56 Million Series A to Advance Novel Cancer Drug Candidates Using T Cell Engager (TRACTr) Technology

Mar 3, 2021 07:00AM AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer

Mar 2, 2021 04:33PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Mar 2, 2021 07:00AM Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments

Mar 2, 2021 07:00AM Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments

Mar 1, 2021 04:02PM Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Mar 1, 2021 08:00AM Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease

Mar 1, 2021 08:00AM DTx Pharma Completes $100M Series B Financing to Advance its FALCON™ Platform and Pipeline of RNA Therapeutics

Mar 1, 2021 07:05AM Satsuma Pharmaceuticals Inc. (STSA) Announces $80 Million Private Placement Financing

Mar 1, 2021 07:00AM Satsuma Pharmaceuticals Announces $80 Million Private Placement Financing

Feb 26, 2021 07:00AM Artiva Biotherapeutics Raises $120 Million in Series B Financing to Advance Pipeline of Allogeneic NK Cell Therapies

Feb 26, 2021 07:00AM PepGen Announces Formation of Scientific Advisory Board

Feb 24, 2021 08:00AM Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs

Feb 24, 2021 06:00AM Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective Immuno-Oncology Pipeline

Feb 19, 2021 04:31PM Form SC 13D Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:21PM Form SC 13G ImmunoGen, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:14PM Form SC 13G MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:09PM Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:08PM Form SC 13G Atea Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:03PM Form SC 13G Frazier Lifesciences Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:02PM Form SC 13G CURIS INC Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 05:02PM Form SC 13G Akouos, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:57PM Form SC 13G Olema Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:57PM Form SC 13G Trillium Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:57PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:57PM Form SC 13G Inozyme Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:52PM Form SC 13G 5:01 Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 16, 2021 04:52PM Form SC 13G BCLS Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.

View More Recent Stories View Older Stories